Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases

scientific article

Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1008745269
P356DOI10.1023/A:1011987206008
P698PubMed publication ID11688963

P50authorMichal ŠmahelQ40512203
P2093author name stringJandlová T
Símová J
Vonka V
Mendoza L
Mikysková R
Bubenik J
P2860cites workHigh-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993Q29619885
Genetically engineered dendritic cell-based cancer vaccines (review).Q34141341
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigensQ34291693
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responsesQ34468846
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival updateQ34507305
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16Q36622535
Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation testsQ39479336
T cell growth factor: parameters of production and a quantitative microassay for activityQ40680131
Vaccination for treatment of tumors: a critical commentQ40921666
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II moleculesQ41120866
Cytokine gene-modified vaccines in the therapy of cancerQ41151865
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.Q41503342
Antitumor and antimetastatic activity of interleukin 12 against murine tumorsQ41906195
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.Q45856436
Gene transfer for immunotherapy of cancerQ45879866
Inhibition of experimental lung metastasis of murine colon carcinoma cells depends on the amount of interleukin-2 secreted from the transduced cells.Q48005880
In situ cytokine therapy: redistribution of clonally expanded T cellsQ56999983
Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicityQ57185273
Influence of the administration schedule on the therapeutic effect of interleukin-2Q68817133
Local and systemic effects during interleukin-2 therapy of mouse mammary tumorsQ68824500
Tumour inhibitory effects of TCGF/IL-2/-containing preparationsQ69866226
Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasisQ71049413
Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic miceQ71257944
Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodesQ72050072
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma productionQ72686394
Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activityQ73243204
Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gammaQ73715471
Impact of the number of treatment courses on the clinical response of patients who receive high-dose bolus interleukin-2Q73719699
Genetically modified tumour vaccinesQ84009352
P433issue7
P304page(s)581-587
P577publication date2000-01-01
P1433published inClinical & Experimental MetastasisQ13470030
P1476titleLocal cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases
P478volume18

Reverse relations

Q42834024Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I moleculescites workP2860

Search more.